Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00941473Phase 4Completed
Phase 4, open-label, single-arm trial of triamcinolone in low back pain (LBP), sponsored by Henry Ford Health. Primary endpoints: Bone Mineral Density at 12 months and Markers of Bone Turnover at 12 months. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00941473.